Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 7.


Belot, Alexandre, Rice, Gillian I, Omarjee, Sulliman Ommar, Rouchon, Quentin, Smith, Eve MD, Moreews, Marion, Tusseau, Maud, Frachette, Cécile, Bournhonesque, Raphael, Thielens, Nicole
et al (show 75 more authors) (2020) Contribution of rare and predicted pathogenic gene variants to childhood-onset lupus: a large, genetic panel analysis of British and French cohorts. The Lancet Rheumatology, 2 (2). e99-e109.


Akthar, Mumina, Nair, Nisha, Carter, Lucy M, Vital, Edward M, Sutton, Emily, McHugh, Neil, British Isles Lupus Assessment Group Biologics Register (BILAG B, , MASTERPLANS Consortium, , Bruce, Ian N and Reynolds, John A ORCID: 0000-0002-8962-4404
(2023) Deconvolution of whole blood transcriptomics identifies changes in immune cell composition in patients with systemic lupus erythematosus (SLE) treated with mycophenolate mofetil. Arthritis research & therapy, 25 (1). 111-.


Carlsson, Emil, Quist, Alexandra, Davies, Jennifer C, Midgley, Angela, Smith, Eve MD, Bruce, Ian N, Beresford, Michael W ORCID: 0000-0002-5400-9911 and Hedrich, Christian M ORCID: 0000-0002-1295-6179
(2022) Longitudinal analysis of urinary proteins in lupus nephritis – A pilot study. Clinical Immunology, 236. p. 108948.


David, Trixy, Su, Li, Cheng, Yafeng, Gordon, Caroline ORCID: 0000-0002-1244-6443, Parker, Benjamin, Isenberg, David ORCID: 0000-0001-9514-2455, Reynolds, John A ORCID: 0000-0002-8962-4404, Bruce, Ian N ORCID: 0000-0003-3047-500X, International Collaborating Clinics Consortium, and MASTERPLANS Consortium,
(2023) Predictors of British Isles Lupus Assessment Group-based outcomes in patients with systemic lupus erythematosus: Analysis from the Systemic Lupus International Collaborating Clinics Inception Cohort. Lupus, 32 (9). pp. 1043-1055.


McDonald, Stephen ORCID: 0000-0001-7151-7654, Yiu, Sean, Su, Li, Gordon, Caroline, Truman, Matt, Lisk, Laura, Solomons, Neil, Bruce, Ian N ORCID: 0000-0003-3047-500X and MASTERPLANS Consortium,
(2022) Predictors of treatment response in a lupus nephritis population: lessons from the Aspreva Lupus Management Study (ALMS) trial. Lupus science & medicine, 9 (1). e000584-.


Davies, Jennifer C, Midgley, Angela, Carlsson, Emil, Donohue, Sean, Bruce, Ian N, Beresford, Michael W ORCID: 0000-0002-5400-9911 and Hedrich, Christian M ORCID: 0000-0002-1295-6179
(2020) Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatment. RMD OPEN, 6 (2). e001257-.


Gavan, Sean P, Bruce, Ian N, Payne, Katherine and MASTERPLANS Consortium,
(2023) Valuing Health Gain from Composite Response Endpoints for Multisystem Diseases. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 26 (1). pp. 115-122.

This list was generated on Sat Mar 30 02:43:20 2024 GMT.